Overview
MDLN market data
Price History
MDLN price chart
Valuation & Profitability
- P/E (TTM)
- 64.12 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $1.43 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.74 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 2.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $32.82 – $50.88 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $44.4B · P/B 4.97 · P/S 1.48.
Company News
Medline Convenience Kits Impacted By Contamination In Recalled Becton Dickinson ProductsBenzinga · Aug 13, 2026, 6:00 PM
JP Morgan Maintains Overweight on Medline, Lowers Price Target to $46Benzinga · Aug 12, 2026, 2:39 PM
Wells Fargo Maintains Equal-Weight on Medline, Lowers Price Target to $34Benzinga · Aug 11, 2026, 1:03 PM
Medline shares are trading lower after TD Cowen lowered its price target on the stock from $53 to $45.Benzinga · Aug 10, 2026, 6:04 PM
TD Cowen Maintains Buy on Medline, Lowers Price Target to $45Benzinga · Aug 10, 2026, 3:32 PM
NASDAQ: MDLN Investigation: Kessler Topaz Meltzer & Check, LLP Encourages Medline Inc. (NASDAQ: MDLN) Investors to Contact the FirmGlobenewswire Inc · Aug 7, 2026, 5:15 PM
Medline shares are trading lower after multiple firms lowered their respective price targets on the stock.Benzinga · Aug 6, 2026, 6:43 PM
RBC Capital Maintains Outperform on Medline, Lowers Price Target to $46Benzinga · Aug 6, 2026, 5:39 PM
Truist Securities Maintains Buy on Medline, Lowers Price Target to $47Benzinga · Aug 6, 2026, 4:04 PM
Evercore ISI Group Maintains Outperform on Medline, Lowers Price Target to $39Benzinga · Aug 6, 2026, 3:31 PM